We therefore identified responders (Ziegler, n = 18; Yoshida, n = 10) and non-responders (Ziegler, n = 16; Yoshida, n = 4) among patients with mild to severe COVID-19, defined as those with or without IFNG mRNA+ T cells, respectively. Here, IFNG is linked to COVID-19.